News 
Market Data 
Discover
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Still low 
Brother still working for wst, good future
$WST DD Notes ~ http://www.ddnotesmaker.com/WST
bullish very long term
$WST recent news/filings
## source: finance.yahoo.com
Thu, 23 Oct 2014 12:52:45 GMT ~ West to Host Third Quarter 2014 Conference Call
[at noodls] - EXTON, PA -- (Marketwired) -- 10/23/14 -- (NYSE: WST) today that it will release third quarter 2014 financial results before the market opens on Thursday, October 30, 2014 and will follow with a conference ...
read full: http://www.noodls.com/view/0BEE0F66A6BFF2C9D7A938147A9B2D3E769763E6
*********************************************************
Thu, 23 Oct 2014 12:00:00 GMT ~ West to Host Third Quarter 2014 Conference Call
[Marketwired] - West Pharmaceutical Services, Inc. today that it will release third quarter 2014 financial results before the market opens on Thursday, October 30, 2014 and will follow with a conference call to discuss ...
read full: http://finance.yahoo.com/news/west-host-third-quarter-2014-120000963.html
*********************************************************
Tue, 21 Oct 2014 12:26:32 GMT ~ West's Vial2Bag DC Device Receives U.S. FDA 510(k) Clearance and CE Mark
[at noodls] - EXTON, Pa., Oct. 21, 2014 /PRNewswire/ -- (NYSE: WST), a global leader in innovative solutions for injectable drug administration, has received 510(k) clearance of the Vial2Bag® DC device from the United ...
read full: http://www.noodls.com/view/D87AD234C5F0952A6D7116757AB79450A33DA934
*********************************************************
Tue, 21 Oct 2014 12:00:00 GMT ~ West's Vial2Bag DC Device Receives U.S. FDA 510(k) Clearance and CE Mark
[PR Newswire] - EXTON, Pa., Oct. 21, 2014 /PRNewswire/ -- West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, has received 510(k) clearance of the Vial2Bag® DC device from the United States Food and Drug Administration, and also the CE Mark for the European Union. The Vial2Bag DC device is produced by West's subsidiary, Medimop Medical Projects Ltd., and is a universal admixture device designed to enable safe, convenient, needle-free reconstitution and transfer of drug products between a vial and a standard IV bag or bottle. Our new Vial2Bag DC device simplifies the IV admixture process and eliminates the risk of needlestick injuries and minimizes potential drug exposure, making this procedure safer and more efficient for healthcare staff," said John Paproski, President, Pharmaceutical Delivery Systems, West Pharmaceutical Services. Progressive Medical Inc. (PMI) will distribute the Vial2Bag DC device to hospitals in the United States.
read full: http://finance.yahoo.com/news/wests-vial2bag-dc-device-receives-120000003.html
*********************************************************
Wed, 15 Oct 2014 14:23:13 GMT ~ West Pharmaceutical Services Warns On FY14, CEO To Retire
read full: http://finance.yahoo.com/news/west-pharmaceutical-services-warns-fy14-142313742.html
*********************************************************
$WST charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$WST company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/WST/company-info
Ticker: $WST
OTC Market Place: Not Available
CIK code: 0000105770
Company name: West Pharmaceutical Services, Inc.
Company website: http://www.westpharma.com
Incorporated In: PA, USA
$WST share structure
## source: otcmarkets.com
Market Value: $3,246,684,941 a/o Oct 27, 2014
Shares Outstanding: 70,764,711 a/o Jun 30, 2014
Float: Not Available
Authorized Shares: Not Available
Par Value: 2.05
$WST extra dd links
Company name: West Pharmaceutical Services, Inc.
Company website: http://www.westpharma.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/WST/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/WST/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=WST+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=WST+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=WST+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/WST/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/WST/news - http://finance.yahoo.com/q/h?s=WST+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/WST/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/WST/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/WST/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/WST/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/WST/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/WST/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/WST/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/WST/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=WST+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/WST
DTCC (dtcc.com): http://search2.dtcc.com/?q=West+Pharmaceutical+Services%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=West+Pharmaceutical+Services%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=West+Pharmaceutical+Services%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.westpharma.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.westpharma.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.westpharma.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/WST/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/WST
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/WST/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/WST/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/WST/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000105770&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/WST/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/WST/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/WST/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/WST/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=WST&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=WST
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/WST/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=WST+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=WST+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=WST
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=WST
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=WST+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/WST/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=WST+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/WST.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=WST
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/WST/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/WST/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/WST/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/WST/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/WST
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/WST
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/WST:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=WST
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=WST
$WST DD Notes ~ http://www.ddnotesmaker.com/WST
~ Thursday! $WST ~ Earnings posted, pending or coming soon! In Charts and Links Below!
~ $WST ~ Earnings expected on Thursday *
Want more like this? Search Keyword: MACMONEY >>> http://tinyurl.com/MACMONEY <<<
One or more of many earnings sites has alerted this security has or will be posting earnings on or around the day of this message.
http://stockcharts.com/h-sc/ui?s=WST&p=D&b=3&g=0&id=p88783918276&a=237480049
http://stockcharts.com/h-sc/ui?s=WST&p=W&b=3&g=0&id=p54550695994
~ Google Finance: http://www.google.com/finance?q=WST
~ Google Fin Options: hhttp://www.google.com/finance/option_chain?q=WST#
~ Yahoo! Finance ~ Stats: http://finance.yahoo.com/q/ks?s=WST+Key+Statistics
~ Yahoo! Finance ~ Profile: http://finance.yahoo.com/q/pr?s=WST
Finviz: http://finviz.com/quote.ashx?t=WST
~ BusyStock: http://busystock.com/i.php?s=WST&v=2
<<<<<< http://www.earningswhispers.com/stocks.asp?symbol=WST >>>>>>
http://investorshub.advfn.com/boards/post_prvt.aspx?user=251916
*If the earnings date is in error please ignore error. I do my best.
|
Followers
|
2
|
Posters
|
|
|
Posts (Today)
|
0
|
Posts (Total)
|
95
|
|
Created
|
04/04/08
|
Type
|
Free
|
| Moderators | |||
http://www.westpharma.com/en/Pages/Default.aspx
http://www.westpharma.com/en/about/Pages/GlobalFacilities.aspx
http://www.pharmaasia.com/2015/04/eric-green-is-new-ceo-at-west-pharma/
-----PLEASE NOTE--------
THIS IS NOT A DAY TRADE STOCK
THIS STOCK HAS AVERAGED 28% PER YEAR FOR 10 YEARS STRAIGHT
2013 2 for 1 stock split
2004 2 for 1 stock split
West Pharmaceutical Services, Inc. manufactures components and systems for injectable drug delivery and plastic packaging, and delivery system components for the healthcare, personal care, and consumer products markets. The company operates in two segments, Pharmaceutical Systems and Tech Group. The Pharmaceutical Systems segment engages in the design, manufacture, and sale of various elastomer, metal, and plastic components used in parenteral drug delivery for the pharmaceutical, generic, and biopharmaceutical industries. It offers various pharmaceutical packaging components, such as stoppers and discs, plungers, seals, dropper bulbs, needle shields and tip caps, and sterile devices. This segment also provides contract analytical laboratory services for testing and evaluating primary drug packaging components. The Tech Group segment produces injection molded components and devices, such as contact lens storage kits, pill dispensers, and disposable blood collection systems for surgical, ophthalmic, diagnostic, and drug delivery systems. This segment also involves in the manufacture and assembly of systems and devices used for nasal, oral, pulmonary, and injectable delivery of drugs used to treat diseases. The company's customers include pharmaceutical, biotechnology, generic drug, and medical-device producers. West Pharmaceutical sells its products primarily in the United States,Asia,Germany,France,and other European countries. It markets its products and services principally through its own sales force and distribution network, as well as through sales agents and distributors. The company was founded in 1923 and is headquartered in Lionville, Pennsylvania.
West Pharmaceutical Services Inc.'s Corporate Governance Quotient (CGQ®) as of 1-Apr-08 is better than 97.2% of S&P 600 companies and 97.9% of Health Care Equipment & Services companies.
Improving Global Healthcare
West helps improve the safe delivery of pharmaceutical, health care and personal care products. Media Relations Contact for North and South America
Second Quarter 2016 Highlights
"Adjusted diluted EPS" and "net sales at constant currency" are Non-GAAP measurements. See discussion under the heading "Non-GAAP Financial Measures" in this release.
Executive Commentary
"We had a successful quarter with solid organic sales growth, increased gross and operating profit margins and new product launches and approvals," said Eric M. Green, President and Chief Executive Officer. "Led by our Commercial group, both the Proprietary Products and Contact-Manufactured Products segments contributed to overall organic sales growth, with broad-based growth in all three market units of Biologics, Generics and Pharma. We continue to see double-digit sales growth in our high-value product offerings including Westar RS® and Westar RU®, Daikyo®, FluroTec® and NovaPure® components."
"We had another strong quarter of gross margin expansion fueled by high-single digit organic sales growth, favorable product mix and operational efficiencies. I am pleased that our Global Operations initiatives are successfully increasing throughput and reducing lead times. As a result, we saw a sequential quarterly reduction in backlog levels and remain on track with our target of achieving faster lead times in the second half of the year and reducing backlog levels that better match underlying demand."
"Earlier this month, the U.S. Food and Drug Administration (FDA) approved the first combination product that incorporates an injectable drug with West's SmartDose® technology for use in the United States. This milestone exemplifies West's strategy of providing the highest quality components and systems to meet our customers' needs for injectable drug delivery solutions; in this case, an integrated containment system that combines the novel SmartDose device with a Daikyo Crystal Zenith® container and a Flurotec® piston. I am proud of the work of our Innovation and Technology team and partners to achieve this milestone. The many years of work and dedication to this project have paved the way for new opportunities for the on-body delivery of injectable drugs."
Mr. Green concluded, "Since the launch of our market-led strategy and business realignment at the start of the year, our teams have performed well, and the company is well positioned for future success. We continue to see solid end-market demand in our Proprietary Products segment and expect to see higher organic sales growth in our Contract-Manufactured Products segment in the second half of the year. With these trends, we are raising our full-year 2016 organic sales growth guidance to a new range of between 7% and 9% and are raising the lower-end of our adjusted diluted EPS guidance
